{"article_title": "A 3 Minute Clinic on CVS Earnings -- The Motley Fool", "article_keywords": ["fool", "adjusted", "retail", "increased", "revenue", "motley", "cvs", "eps", "clinic", "growth", "earnings", "pharmacy", "minute", "14"], "article_url": "http://www.fool.com/investing/general/2014/05/15/a-3-minute-clinic-on-cvs-earnings.aspx", "article_text": "CVS Caremark (NYSE:CVS) reported a mixed Q1, although the fundamentals may have been stronger than the headlines indicated. After all, adjusted EPS grew by 22.5% to $1.02, while revenue increased 6.3% to $32.7 billion.\n\nAnd while the Pharmacy Services Segment (the PBM portion of the business) led the charge with a 10.3% bump in revenue, retail pharmacy revenue still increased by 2.7%, driven by a same store sales increase of 1.4%. And MinuteClinic revenue climbed 11%. This all happened despite some pretty nasty winter weather which affected foot traffic across the retail space.\n\nThe company maintained its guidance, for 5.3% to 6.5% revenue growth and 10% to 14% growth in adjusted EPS, which highlights the company's continued growth prospects.\n\nThere was a lot to be excited about in the earnings. In the video below, Motley Fool health care analysts Michael Douglass and David Williamson dig in with a quick 3 minute clinic on CVS' earnings.", "article_metadata": {"publish_time": "09:13", "date": "2014-05-15T13:13:00Z", "description": "CVS reported earnings. Here are the major takeaways.", "ResponsiveALP": "1Ses_control-21_control_100", "author": "Michael Douglass and Dave Williamson", "promo": "CVS reported earnings. Here are the major takeaways.", "twitter": {"site": "@themotleyfool", "description": "CVS reported earnings. Here are the major takeaways.", "title": "A 3 Minute Clinic on CVS Earnings --  The Motley Fool"}, "pitch": 681, "og": {"site_name": "The Motley Fool", "description": "CVS reported earnings. Here are the major takeaways.", "title": "A 3 Minute Clinic on CVS Earnings --  The Motley Fool", "url": "http://www.fool.com/investing/general/2014/05/15/a-3-minute-clinic-on-cvs-earnings.aspx", "image": "https://g.foolcdn.com/image/?url=http%3A%2F%2Fg.foolcdn.com%2Fassets%2Fimages%2Ffool%2Ftmf-logo.png&h=630&w=1200&op=resize", "type": "article"}, "fb": {"admins": 50808187550, "page_id": 7240312795, "app_id": 50808187550}, "bureau": "usmf-health-care", "STORY_UID": "f7428da6-dbb7-11e3-9b90-0050569d4be0", "headline": "A 3 Minute Clinic on CVS Earnings", "msvalidate.01": "8D40D58712924715BAA79D135A6C8DDA", "gsa_date": "2014 05 15", "tickers": "CVS", "viewport": "width=device-width, initial-scale=1.0, maximum-scale=1.0"}, "_id": "\"57477af46914bd0286fdcde7\"", "article_summary": "In the video below, Motley Fool health care analysts Michael Douglass and David Williamson dig in with a quick 3 minute clinic on CVS' earnings.\nAfter all, adjusted EPS grew by 22.5% to $1.02, while revenue increased 6.3% to $32.7 billion.\nThe company maintained its guidance, for 5.3% to 6.5% revenue growth and 10% to 14% growth in adjusted EPS, which highlights the company's continued growth prospects.\nCVS Caremark (NYSE:CVS) reported a mixed Q1, although the fundamentals may have been stronger than the headlines indicated.\nAnd while the Pharmacy Services Segment (the PBM portion of the business) led the charge with a 10.3% bump in revenue, retail pharmacy revenue still increased by 2.7%, driven by a same store sales increase of 1.4%."}